CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.91 -0.20 (-3.82%)
As of: Sep 29, 2026 · 10:17 AM EDT

CNS Pharmaceuticals (CNSP) Share-based Compensation (2018 - 2025)

Updated

CNS Pharmaceuticals (CNSP) posted Share-based Compensation of $85,068 for Q4 2025, down 34.5% from $129,900 a year earlier but up 361.0% from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Share-based Compensation (2018 - 2025) Analysis & Trends

For FY2025, CNS Pharmaceuticals' Share-based Compensation came in at $187,728, down 77.6% from FY2024.

  • Annual Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
  • In prior years, CNS Pharmaceuticals' Share-based Compensation was $838,957 in FY2024 (-16.7%), $1.01 million in FY2023 (-16.3%), $1.2 million in FY2022 (-30.2%) and $1.72 million in FY2021 (+33.3%).
  • Quarterly Share-based Compensation has run from a low of $18,452 in Q3 2025 to a high of $506,647 in Q3 2021 over five years.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last five quarters, with an average decline of 42.7% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2021, with growth of 77.8%; the weakest was Q3 2025, with a decline of 93.2%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $18,452 (Q3 2025), $21,841 (Q2 2025) and $62,367 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 CNS Pharmaceuticals 2.30 Mn -39.94 Mn - 85,068.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 85,068.00
Sep 30, 2025 18,452.00
Jun 30, 2025 21,841.00
Mar 31, 2025 62,367.00
Dec 31, 2024 129,900.00
Sep 30, 2024 271,779.00
Jun 30, 2024 234,345.00
Mar 31, 2024 202,933.00
Dec 31, 2023 232,675.00
Sep 30, 2023 194,759.00
Jun 30, 2023 289,670.00
Mar 31, 2023 290,313.00
Dec 31, 2022 289,719.00
Sep 30, 2022 289,721.00
Jun 30, 2022 286,841.00
Mar 31, 2022 336,685.00
Dec 31, 2021 316,906.00
Sep 30, 2021 506,647.00
Jun 30, 2021 469,610.00
Mar 31, 2021 430,679.00
API Access

CNS Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CNSP&period=max&api_key=YOUR_API_KEY